Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.286ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.286ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.286EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.286EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.286ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.286ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.369EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.369EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.369ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.369ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.369EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.369EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.369ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.369ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.69EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.69ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.69ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.69EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.69EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used